LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Home・Stock List・IQVIA Holdings Inc

IQVIA Holdings Inc

Closed

Sector Healthcare

209.18 1.27

Buy Sell

Overview

Share price change

24h

Current

Min

208.77

Max

210.14

Key metrics
By Trading Economics
Income	-78M 285M
Sales	90M 3.9B
P/E Sector Avg	28.89 104.138
EPS	2.84
Profit margin	7.308
Employees	87,000
EBITDA	-12M 856M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+24.13 upside

Market Stats
By TradingEconomics
Market Cap	-4.9B 37B
Previous open	207.91
Previous close	209.18

News Sentiment

By Acuity

50%

167 / 390 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

200.3 / 214.63 Support & Resistance

IQVIA Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

3 Nov 2024, 23:05 UTC

Top News

Fitch Affirms Australia's Sovereign AAA Rating, But Warns Of Mounting Budget Risks

3 Nov 2024, 21:12 UTC

Earnings

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects -- Update

3 Nov 2024, 20:59 UTC

Earnings

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects

3 Nov 2024, 23:34 UTC

Top News

Stocks Poised for Lower Open -- Barrons.com

3 Nov 2024, 23:16 UTC

Earnings

Berkshire Hathway Earnings Weren't as Bad as They Looked -- Barrons.com

3 Nov 2024, 22:50 UTC

Acquisitions, Mergers, Takeovers

Santos Says Working Interest in PNG LNG Now 39.9%

3 Nov 2024, 22:50 UTC

Acquisitions, Mergers, Takeovers

Santos Says Kumul to Assume $90 Million of Project Finance Debt Associated With Stake

3 Nov 2024, 22:49 UTC

Acquisitions, Mergers, Takeovers

Santos Says Final Payment Takes Total Cash Consideration to $602 Million

3 Nov 2024, 22:49 UTC

Acquisitions, Mergers, Takeovers

Santos Receives Final $241 Million Payment From Kumul

3 Nov 2024, 22:48 UTC

Acquisitions, Mergers, Takeovers

Santos Completes Sale of 2.6% Interest in PNG LNG to Kumul Petroleum

3 Nov 2024, 20:37 UTC

Earnings

Westpac FY 2024 Deposits Increased 5% to A$674 Billion

3 Nov 2024, 20:37 UTC

Earnings

Westpac FY 2024 Loans Increased 4% to A$807 Billion

3 Nov 2024, 20:37 UTC

Earnings

Westpac FY 2024 Impairment Charges 7 Bps of Loans

3 Nov 2024, 20:37 UTC

Earnings

Westpac FY 2024 Operating Expenses A$10.94 Billion, Up 7% Excluding Notable Items

3 Nov 2024, 20:36 UTC

Earnings

Westpac FY 2024 Non-Interest Income A$2.84 Billion, Down 15%

3 Nov 2024, 20:35 UTC

Earnings

Westpac FY 2024 CET1 Level 2 Capital Ratio 12.5%, Up 11 Bps

3 Nov 2024, 20:35 UTC

Earnings

Westpac Raises Share Buyback Program by A$1 Billion

3 Nov 2024, 20:35 UTC

Earnings

Westpac Final Dividend A$0.76/Share

3 Nov 2024, 20:33 UTC

Earnings

Westpac FY 2024 Net Interest Margin Down 1 Bps at 1.95%

3 Nov 2024, 20:32 UTC

Earnings

Westpac FY 2024 Revenue A$21.59 Billion, Flat on FY 2023

3 Nov 2024, 20:32 UTC

Earnings

Westpac FY Net Profit A$6.99 Billion, Down 3%

3 Nov 2024, 18:09 UTC

Top News

Boeing Had a Big Week. This One Is Even Bigger. -- Barrons.com

3 Nov 2024, 10:30 UTC

Top News

Fed Prepares Rate Cut Amid Economic Contradictions -- WSJ

3 Nov 2024, 03:00 UTC

Top News

Disgraced Lebanese Central Banker Who Was a Fugitive Now Awaits His Fate -- WSJ

2 Nov 2024, 13:53 UTC

Top News

Earnings

Acquisitions, Mergers, Takeovers

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update

2 Nov 2024, 13:44 UTC

Earnings

Acquisitions, Mergers, Takeovers

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 Nov 2024, 13:00 UTC

Top News

China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ

2 Nov 2024, 12:58 UTC

Earnings

Acquisitions, Mergers, Takeovers

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 Nov 2024, 12:48 UTC

Top News

Earnings

Acquisitions, Mergers, Takeovers

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ

2 Nov 2024, 12:32 UTC

Earnings

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

Peer Comparison

Price change

IQVIA Holdings Inc Forecast

Price Target

By TipRanks

24.13% upside

12 Months Forecast

Average 259.64 USD 24.13%

High 279 USD

Low 235 USD

Based on 13 Wall Street analysts offering 12 month price targets forIQVIA Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

Buy

Hold

Sell

Based on 13 analysts giving stock ratings to IQVIA Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

200.3 / 214.63Support & Resistance

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

167 / 390 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About IQVIA Holdings Inc

IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides critical information, technology solutions and real-world insights and services to the Company's life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, providing outsourced clinical research and clinical trial related services. The Contract Sales & Medical Solutions segment provides health care provider, including contract sales and patient engagement services to both biopharmaceutical clients and the broader healthcare market. The Company protects individual patient privacy. The Company conducts business in more than 100 countries.